Literature DB >> 31037850

Wirksamkeit des IL-17-Hemmers SECUKINUMAB bei akuter generalisierter exanthematische Pustulose (AGEP).

Bruno Gualtieri1,2, Christian Möbs1, Farzan Solimani1, Michael Hertl1, Wolfgang Pfützner1.   

Abstract

Year:  2019        PMID: 31037850     DOI: 10.1111/ddg.13785

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  1 in total

1.  Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine.

Authors:  Mohammad Munshi; Alexandra Junge; Karolina Gadaldi; Nikhil Yawalkar; Kristine Heidemeyer
Journal:  JAAD Case Rep       Date:  2020-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.